Home / Compounds / Recovery

Recovery

Recovery covers 4 compounds on WikiPep: KPV, BPC-157, TB-500 and BPC-157 / TB-500. Across them, 2 of the 27 uses listed here have been studied in human trials of that compound.

None of these is FDA-approved, and nearly all the evidence comes from animal and lab studies. For TB-500, most of it is on its full-length parent protein, thymosin beta-4, not the fragment itself. In July 2026 an FDA advisory committee narrowly recommended BPC-157, TB-500 and KPV for the compounding list; the vote is advice, not a decision.

Tissue and joint repair. Every use below carries an evidence label, so you can see what has been studied in people and what has not.

KPVAnti-inflammatory tripeptide 200–500 mcg Once daily 5 uses · none human-studied BPC-157Body protection compound 200–500 mcg Once or twice daily 7 uses · 1 human-studied TB-500Thymosin beta-4 (repair protein) 250–2500 mcg Once daily 8 uses · 1 human-studied BPC-157 / TB-500BPC-157 / TB-500 blend 500–1000 mcg Once daily 7 uses · none human-studied

Each one, in plain words

  • KPV: KPV is a tiny peptide, just three amino acids long, cut from the end of alpha-MSH, a natural hormone. It keeps the hormone’s anti-inflammatory activity but not its effect on skin color.
  • BPC-157: BPC-157 is a small lab-made peptide based on a protein found in human stomach juice, and it is not an approved medicine.
  • TB-500: TB-500 is the name sold for thymosin beta-4, a natural repair protein the body keeps in nearly every cell. Some sellers use the name for a short piece of it instead.
  • BPC-157 / TB-500: The BPC-157 / TB-500 blend, often called the Wolverine stack, puts two popular repair peptides in one vial.

Related news

Working out a dose? The calculator turns a vial size and a dose into units on a syringe, and the mixing guide covers reconstitution.